logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Essex Bio-Technology (01061.HK) repurchased 28,000 shares for HK$56,300 on November 3.

date
03/11/2026
Zhitong Finance APP News, Essex Bio-Technology (01061.HK) announced that on November 3, 2026, it spent HK$56,300 to repurchase 28,000 shares.
Latest
13 m ago
HG partners with Anthropic to invest in a new AI startup.
15 m ago
Zhitong Finance APP News, Sunac Services (01516.HK) announced that on November 3, 2026, the company spent HK$134,900 to repurchase 200,000 shares at a repurchase price of HK$0.67-0.68 per share.
15 m ago
Zhitong Finance APP news, Yongan Futures (600927.SH) issued an announcement that on November 2, 2026, the company's wholly-owned overseas subsidiary Yongan International Financial (UK) Co. Limited received a notice from the UK Financial Conduct Authority (hereinafter referred to as "FCA"), approving the acquisition of FCA investment firm authorization to conduct, in the UK, for professional clients and eligible counterparties, regulated activities including trade matching, agency and principal dealing in commodity futures, commodity options and other derivatives, and holding client money.
18 m ago
Zhitong Finance APP News, Dongrui Pharmaceutical (02348.HK) announced that on November 3, 2026, it spent HK$92,500 to repurchase 100,000 shares.
22 m ago
China Resources Double-Crane (600062.SH): Isavuconazole Sulfate for Injection and Others Obtain Drug Registration Certificates
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.